- In October 2023, Biosynth acquired Pepceuticals Limited, a leading British synthetic peptide manufacturer, to bolster its peptide division. This strategic acquisition aims to enhance Biosynth's capabilities in the peptide market, expand its product offerings, and improve its competitive position in the growing peptide therapeutics and bioactive peptide space
- In June 2023, Italian contract research organization IRBM and Merck & Co. Inc. renewed their collaboration in the peptide therapeutics field. This partnership allows Merck to leverage IRBM’s expertise and resources, including clinical trial design and execution, to accelerate the development of innovative peptide-based therapies for a variety of diseases
- In March 2023, Ono Pharmaceuticals and PeptiDream entered a partnership focused on drug discovery and the development of Macrocyclic Constrained Peptide Therapeutics. This collaboration aims to explore new therapeutic opportunities using advanced peptide technologies, with the goal of creating innovative treatments for various diseases, including cancer and neurological disorders
- In January 2021, Darling Ingredients Inc. launched Peptan® Marine collagen peptides sourced from wild-caught marine white fish. This move was designed to help beauty and nutrition brands expand their product offerings, enabling them to cater to the increasing demand for premium dietary supplements that promote skin health, joint function, and overall wellness
- In January 2021, Gelita AG introduced new collagen peptides as part of its proprietary Bioactive Collagen Peptides (BCP) portfolio. The launch aims to meet the rising consumer demand for improved immunity, offering a solution to consumers seeking to enhance their immune system through bioactive collagen peptides and addressing health and wellness trends
- In February 2020, Tessenderlo Group-owned PB Leiner expanded its production capacity by opening a new site in Argentina. This expansion enables the company to significantly increase the production of SOLUGEL collagen peptides, meeting the growing global demand for high-quality collagen products in the food, health, and nutrition sectors
Frequently Asked Questions
The market is segmented based on Segmentation, By Product Type (Bioactive Peptides, Collagen Peptides, Whey Protein Peptides, Muscle-building Peptides, Anti-aging Peptides and Immune-enhancing Peptides), Source (Animal-Derived, Plant-Derived and Synthetic Peptides), Functionality (Muscle Recovery, Weight Management, Skin Health, Immune Support, Cognitive function, Anti-Inflammatory and Cardiovascular Health), Product Format (Powder, Tablets / Capsules, Chews / Soft Gels, Liquid and Oral Strips), Distribution Channel (Online Retail, Pharmacies, Specialty Nutrition Stores, Supermarkets, Direct Sales and Healthcare Institutions) – Industry Trends and Forecast to 2032
.
The Global Peptide Supplements Market size was valued at USD 2.67 USD Billion in 2024.
The Global Peptide Supplements Market is projected to grow at a CAGR of 5.5% during the forecast period of 2025 to 2032.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.